Oxford Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-6,847
Closed -$1M 2073
2019
Q1
$1M Sell
6,847
-61,020
-90% -$8.85M 0.02% 928
2018
Q4
$9.07M Buy
67,867
+36,630
+117% +$6M 0.24% 86
2018
Q3
$5.97M Sell
31,237
-16,878
-35% -$3.1M 0.12% 179
2018
Q2
$8.09M Buy
48,115
+34,676
+258% +$5.57M 0.16% 135
2018
Q1
$2.26M Buy
+13,439
New +$2.25M 0.05% 509
2017
Q2
Sell
-12,414
Closed -$2.97M 1791
2017
Q1
$2.97M Buy
12,414
+9,166
+282% +$2.13M 0.07% 293
2016
Q4
$682K Sell
3,248
-35,394
-92% -$7.33M 0.02% 543
2016
Q3
$8.9M Sell
38,642
-7,878
-17% -$1.93M 0.27% 80
2016
Q2
$10.8M Sell
46,520
-296,096
-86% -$68.3M 0.35% 54
2016
Q1
$91.8M Buy
342,616
+164,623
+92% +$47.1M 2.63% 4
2015
Q4
$56.1M Buy
+177,993
New +$53M 1.32% 12
2015
Q3
Sell
-19,815
Closed -$6.01M 756
2015
Q2
$6.01M Buy
+19,815
New +$5.91M 0.16% 146
2014
Q2
Sell
-94,119
Closed -$19.4M 817
2014
Q1
$19.4M Buy
+94,119
New +$18.6M 0.56% 25

Other funds holding AGN

Oxford Asset Management's AGN Position: Q2 2019 in Review

Oxford Asset Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 6,847 shares — an estimated $1M sold.

Oxford Asset Management first reported a position in AGN in Q1 2014 and held it in 13 quarters. The position peaked at $91.8M in Q1 2016. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Oxford Asset Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Oxford Asset Management sold 6,847 Allergan plc shares in Q2 2019, an estimated $1M.
  • Oxford Asset Management first reported a position in Allergan plc in Q1 2014 and held it in 13 quarters.
  • Oxford Asset Management's Allergan plc position peaked at $91.8M in Q1 2016.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Oxford Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.